A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...

"Yo-yo" dieting --- repeatedly losing and gaining weight -- can significantly increase risk of kidney disease among people ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Share on Pinterest An SGLT-2 inhibitor drug plus a moderately calorie-restrictive diet ... 1.3 billion by 2050. “Diabetes has been considered as an incurable illness and is dependent on ...

Adults with type 2 diabetes using a GLP-1 drug have a similar risk for thyroid cancer as those using other diabetes drugs, though increased thyroid cancer risk was observed in the first year after ...